Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 46Liver Neoplasms 9Neoplasm Metastasis 4Leukemia, Myeloid, Acute 4Pancreatic Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Sarcoma 2Recurrence 2Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Breast Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Relapsed Pediatric Solid Tumor 1Portal Vein Tumor Thrombus 1Neoplasms, Glandular and Epithelial 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Site 1Neoplasms by Histologic Type 1Mesothelioma 1Lung Neoplasms 1Liver Diseases 1Leukemia, Monocytic, Acute 1Kidney Neoplasms 1Hemangiosarcoma 1HCC 1Gastrointestinal Neoplasms 1

Interventions

Sorafenib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Liver Cancer × Sorafenib × Clear all
NCT04163237 2019-11-14

Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer

Guangxi Medical University

Phase 3 Unknown
50 enrolled

Advanced Liver Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡